| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-07 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.2 | 2e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.2 | 4e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0004 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |